325 related articles for article (PubMed ID: 36467417)
1.
Canciello A; Cerveró-Varona A; Peserico A; Mauro A; Russo V; Morrione A; Giordano A; Barboni B
Front Cell Dev Biol; 2022; 10():1038841. PubMed ID: 36467417
[TBL] [Abstract][Full Text] [Related]
2. Quantifying Cancer Epithelial-Mesenchymal Plasticity and its Association with Stemness and Immune Response.
Jia D; Li X; Bocci F; Tripathi S; Deng Y; Jolly MK; Onuchic JN; Levine H
J Clin Med; 2019 May; 8(5):. PubMed ID: 31121840
[TBL] [Abstract][Full Text] [Related]
3. Epithelial-Mesenchymal Plasticity in Tumor Immune Evasion.
Mullins RDZ; Pal A; Barrett TF; Heft Neal ME; Puram SV
Cancer Res; 2022 Jul; 82(13):2329-2343. PubMed ID: 35363853
[TBL] [Abstract][Full Text] [Related]
4. Epithelial-to-Mesenchymal Transition in the Light of Plasticity and Hybrid E/M States.
Bornes L; Belthier G; van Rheenen J
J Clin Med; 2021 May; 10(11):. PubMed ID: 34072345
[TBL] [Abstract][Full Text] [Related]
5. Hybrid epithelial/mesenchymal phenotypes promote metastasis and therapy resistance across carcinomas.
Jolly MK; Somarelli JA; Sheth M; Biddle A; Tripathi SC; Armstrong AJ; Hanash SM; Bapat SA; Rangarajan A; Levine H
Pharmacol Ther; 2019 Feb; 194():161-184. PubMed ID: 30268772
[TBL] [Abstract][Full Text] [Related]
6. Emerging Concepts of Hybrid Epithelial-to-Mesenchymal Transition in Cancer Progression.
Sinha D; Saha P; Samanta A; Bishayee A
Biomolecules; 2020 Nov; 10(11):. PubMed ID: 33207810
[TBL] [Abstract][Full Text] [Related]
7. Implications of the Hybrid Epithelial/Mesenchymal Phenotype in Metastasis.
Jolly MK; Boareto M; Huang B; Jia D; Lu M; Ben-Jacob E; Onuchic JN; Levine H
Front Oncol; 2015; 5():155. PubMed ID: 26258068
[TBL] [Abstract][Full Text] [Related]
8. Hypoxia, partial EMT and collective migration: Emerging culprits in metastasis.
Saxena K; Jolly MK; Balamurugan K
Transl Oncol; 2020 Nov; 13(11):100845. PubMed ID: 32781367
[TBL] [Abstract][Full Text] [Related]
9. Hybrid E/M Phenotype(s) and Stemness: A Mechanistic Connection Embedded in Network Topology.
Pasani S; Sahoo S; Jolly MK
J Clin Med; 2020 Dec; 10(1):. PubMed ID: 33375334
[TBL] [Abstract][Full Text] [Related]
10. Stability of the hybrid epithelial/mesenchymal phenotype.
Jolly MK; Tripathi SC; Jia D; Mooney SM; Celiktas M; Hanash SM; Mani SA; Pienta KJ; Ben-Jacob E; Levine H
Oncotarget; 2016 May; 7(19):27067-84. PubMed ID: 27008704
[TBL] [Abstract][Full Text] [Related]
11. NFATc Acts as a Non-Canonical Phenotypic Stability Factor for a Hybrid Epithelial/Mesenchymal Phenotype.
Subbalakshmi AR; Kundnani D; Biswas K; Ghosh A; Hanash SM; Tripathi SC; Jolly MK
Front Oncol; 2020; 10():553342. PubMed ID: 33014880
[TBL] [Abstract][Full Text] [Related]
12. Epithelial, mesenchymal and hybrid epithelial/mesenchymal phenotypes and their clinical relevance in cancer metastasis.
Garg M
Expert Rev Mol Med; 2017 Mar; 19():e3. PubMed ID: 28322181
[TBL] [Abstract][Full Text] [Related]
13. Stemness of the hybrid Epithelial/Mesenchymal State in Breast Cancer and Its Association with Poor Survival.
Grosse-Wilde A; Fouquier d'Hérouël A; McIntosh E; Ertaylan G; Skupin A; Kuestner RE; del Sol A; Walters KA; Huang S
PLoS One; 2015; 10(5):e0126522. PubMed ID: 26020648
[TBL] [Abstract][Full Text] [Related]
14. Communication Between Epithelial-Mesenchymal Plasticity and Cancer Stem Cells: New Insights Into Cancer Progression.
Zheng X; Dai F; Feng L; Zou H; Feng L; Xu M
Front Oncol; 2021; 11():617597. PubMed ID: 33968721
[TBL] [Abstract][Full Text] [Related]
15. Emerging roles of epithelial-mesenchymal plasticity in invasion-metastasis cascade and therapy resistance.
Garg M
Cancer Metastasis Rev; 2022 Mar; 41(1):131-145. PubMed ID: 34978017
[TBL] [Abstract][Full Text] [Related]
16. A mechanism-based computational model to capture the interconnections among epithelial-mesenchymal transition, cancer stem cells and Notch-Jagged signaling.
Bocci F; Jolly MK; George JT; Levine H; Onuchic JN
Oncotarget; 2018 Jul; 9(52):29906-29920. PubMed ID: 30042822
[TBL] [Abstract][Full Text] [Related]
17. Generation of Stable Epithelial-Mesenchymal Hybrid Cancer Cells with Tumorigenic Potential.
Tedja R; Alvero AB; Fox A; Cardenas C; Pitruzzello M; Chehade H; Bawa T; Adzibolosu N; Gogoi R; Mor G
Cancers (Basel); 2023 Jan; 15(3):. PubMed ID: 36765641
[TBL] [Abstract][Full Text] [Related]
18. Measuring and Modelling the Epithelial- Mesenchymal Hybrid State in Cancer: Clinical Implications.
Jolly MK; Murphy RJ; Bhatia S; Whitfield HJ; Redfern A; Davis MJ; Thompson EW
Cells Tissues Organs; 2022; 211(2):110-133. PubMed ID: 33902034
[TBL] [Abstract][Full Text] [Related]
19. Biophysical and biochemical attributes of hybrid epithelial/mesenchymal phenotypes.
Subbalakshmi AR; Ashraf B; Jolly MK
Phys Biol; 2022 Feb; 19(2):. PubMed ID: 34986465
[TBL] [Abstract][Full Text] [Related]
20. Testing the gene expression classification of the EMT spectrum.
Jia D; George JT; Tripathi SC; Kundnani DL; Lu M; Hanash SM; Onuchic JN; Jolly MK; Levine H
Phys Biol; 2019 Jan; 16(2):025002. PubMed ID: 30557866
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
